MetLife (NYSE:MET – Get Free Report) had its price target lifted by TD Cowen from $97.00 to $99.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the financial services provider’s stock. TD Cowen’s target price would suggest a potential upside of 12.18% from the company’s previous close.
MET has been the topic of a number of other research reports. Morgan Stanley dropped their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Wells Fargo & Company lifted their price target on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Piper Sandler upped their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Monday. Finally, Barclays dropped their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $88.62.
Check Out Our Latest Stock Analysis on MetLife
MetLife Trading Up 0.6 %
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. MeadowBrook Investment Advisors LLC boosted its position in shares of MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after buying an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. lifted its stake in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 186 shares during the period. Wolff Wiese Magana LLC boosted its holdings in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife in the third quarter worth approximately $30,000. Finally, Fortitude Family Office LLC raised its holdings in shares of MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 266 shares during the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Bank Stocks – Best Bank Stocks to Invest In
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Overbought Stocks Explained: Should You Trade Them?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Market Cap Calculator: How to Calculate Market Cap
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.